C-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 505-511

  Chen, Cheng ^a   Cai, Shaoxin ^a   Wang, Guihua ^a   Cao, Xiaonian ^a   Yang, Xi ^a   Luo, Xuelai ^a   Feng, Yongdong ^a   Hu, Junbo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; C Myc; Colon cancer; HIF 1 ; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-MYC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872327077     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.006     Document Type: Article

References (33)

1. Brahimi-Horn M.C., Pouyssegur J. HIF at a glance. J. Cell. Sci. 2009, 122:1055-1057.
2. Pez F., Dayan F., Durivault J., Kaniewski B., Aimond G., Le Provost G.S., Deux B., Clezardin P., Sommer P., Pouyssequr J., Reynaud C. The HIF-1-inducible lysyl oxidase activates HIF-1via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 2011, 71:1647-1657.
3. Brahimi-Horn C., Mazure N., Pouyssegur J. Signaling via the hypoxia-inducible factor-1 alpha requires multiple posttranslational modifications. Cell. Signalling 2005, 17:1-9.
4. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 1996, 271:32253-32259.
5. Kallio P.J., Pongratz I., Gradin K., McGuire J., Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Nat. Acad. Sci. USA 1997, 94:5667-5672.
6. Pugh C.W., Ratcliffe P.J. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 2003, 13:83-89.
7. Liao D.J., Dickson R.B. C-Myc in breast cancer. Endocr. Relat. Cancer 2000, 7:143-164.
8. Weng W., Yang Q., Huang M., Qiao Y., Xie Y., Yu Y., Jing A., Li Z. C-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochem. Biophys. Res. Commun. 2011, 405:278-284.
9. Dang C.V., O'Donnell K.A., Zeller K.I., Nguyen T., Osthus R.C., Li F. The c-Myc target gene network. Semin. Cancer Biol. 2006, 16:253-264.
10. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 2005, 6:635-645.
11. Dang C.V. Myc on the path to cancer. Cell 2012, 149:22-35.
12. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126:663-676.
13. Osthus R.C., Shim H., Kim S., Li Q., Reddy R., Mukherjee M., Wonsey D., Lee L.A., Dang C.V. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem. 2000, 275:21797-21800.
14. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces Myc-dependent apoptosis in human cells. J. Cell. Biol. 2007, 178:93-105.
15. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., Semenza G.L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007, 11:407-420.
16. Corn P.G., Ricci M.S., Scata K.A., Arsham A.M., Simon M.C., Dicker D.T., EI-Deiry W.S. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol. Ther. 2005, 4:1285-1294.
17. Gordan J.D., Thompson C.B., Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12:108-113.
18. Tian T., Nan K.J., Wang S.H., Liang X., Lu C.X., Guo H., Wang W.J., Ruan Z.P. PTEN regulates angiogenesis and VEGF espression through phosphatase-depedent and -independent mechanisms in HepG2 cells. Carcinogenesis 2010, 31:1211-1219.
19. Schmittgen T.D., Livak K.J. Analyzing Real-time PCR data by the comparative C (T) method. Nat. Protoc. 2008, 3:1101-1108.
20. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324:1-8.
21. Weidemann A., Johnson R.S. Biology of HIF-1α. Cell. Death Differ. 2008, 15:621-627.
22. Hicklin D.J., Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 2005, 23:1011-1027.
23. Nakamura K., Taquchi E., Miura T., Yamamoto A., Takahashi K., Bichat F., Guilbaud N., Haseqawa K., Kubo K., Fujiwara Y., Suzuki R., Kubo K., Shibuya M., Isae T. KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res. 2006, 66:9134-9142.
24. Hwang C., Heath E.I. Angiogenesis inhibitors in the treatment of prostate cancer. J. Hematol. Oncol. 2010, 3:26-38.
25. Myant K., Sansom Q.J. Wnt/Myc interactions in the intestinal cancer: partners in crime. Exp. Cell. Res. 2011, 317:2725-2731.
26. Wright J.B., Brown S.J., Cole M.D. Upregulation of c-Myc in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancerr cells. Mol. Cell. Biol. 2010, 30:1411-1420.
27. Kim J.W., Gao P., Liu Y.C., Semenza G.L., Dang C.V. HIF-1 and dysregulated c-Myc cooperatively induces VEGF and metabolic switches, HK2 and PDK1. Mol. Cell. Biol. 2007, 27:7381-7393.
28. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 2008, 8:51-56.
29. Yeung S.J., Pan J., Lee M.H. Roles of p53, Myc and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
30. Doe M.R., Ascano J.M., Kaur M., Cole M.D. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Res. 2012, 72:949-957.
31. Bergers G., Benjiamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3:401-410.
32. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
33. Ellis L.M., Hichlin D.J. VEGF-targeted therapy: mechanisms of anti-tumor activity. Nat. Rev. Cancer 2008, 8:579-591.